Page 160 - FINAL PROGRAM

P-435 Long-term melatonin treatment for the prevention of ovarian aging
H. Tamura (Japan)
P-436 Unique geometry of sister kinetochores in human oocytes during meiosis I may explain maternal age-associated increases in chromosomal abnormalities
J. Patel (United Kingdom)
P-437 Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study
Z. Chen (China)
P-438 Localization of toll like receptors(TLRs) in human fallopian tube epithelial cells
A. FatemehSadat (Iran)
P-439 Three dimensional ultrasound and hysteroscopy in diagnosing benign intrauterine lesions in infertile women
D. Baldini (Italy)
P-440 Preclinical data support the safety of egg precursor cell (EggPC) repositioning using a method designed to address poor response to controlled ovarian stimulation
Y. White (U.S.A.)
P-441 MMPs and TIMPs gene expression regulates the human ovarian follicle, a microenvironment for oocyte differentiation
A. Capaldo (Italy)
P-442 Immature oocyte collection during ovarian tissue harvesting and cryopreservation. What is the yield and outcome?
A. Kedem (Israel)
P-443 Egg donors’ characteristics and acceptance procedure according to the Israeli egg donation law
R. Ron - El (Israel)
P-444 Uterine function and its relation with pregnancy complications and outcomes among childhood cancer survivors treated with radiotherapy involving the uterus
L. van de Loo (The Netherlands)
P-445 Freeze all policy in cases of high risk of ovarian hyperstimulation syndrome does not impair cumulative pregnancy rates in a center with slow freezing program
P. Moreno Fernandez (Spain)
P-446 Immature myeloid cells in reproductive system versus tumor angiogenesis
R. Hertz (Israel)
P-447 Current but not former use of combined contraception is associated with glucose metabolism disorders in premenopausal women: a prospective population-based cohort study
M. Mosorin (Finland)
156